Monocytes to high-density lipoproteins ratio as an indicator of inflammation and oxidative stress in patients with various conditions of the gallbladder
Abstract
Introduction. The monocytes to high-density lipoproteins ratio (M/HDL) is known as an integral indicator of inflammation, oxidative stress and lipid accumulation, which allows its use in the assessment and prediction of a number of diseases.
Purpose: to determine the clinical significance of M/HDL according to the literature and to establish its changes and correlations.
Materials and methods. We made a literature search in the Pubmed database and domestic sources, and analyzed data of 1190 outpatients with various diagnoses and 116 inpatients with unstable angina (UA). Digital data were statistically processed with Statistica 6.0.
Results and discussion. Elevated M/HDL is associated with the development of atrial fibrillation after coronary artery bypass grafting, hospital mortality, and all-cause mortality. M/HDL can be a criterion of inflammation and oxidative stress, as well as a predictor of the severity of coronary heart disease and the risk of cardiovascular events. According to own data, in 1190 outpatients the average level of M/HDL was 6.50 ± 0.21. The increase in the M/HDL ratio occurred in parallel with an increase in the number of blood basophils, the development of intrahepatic cholestasis, increased endogenous intoxication, decreased total cholesterol and fasting blood glucose, and diastolic left ventricular dysfunction. In patients with UA M/HDL averaged 5.41 ± 0.40. An increase in the M/HDL ratio was associated with male gender, a decrease in total cholesterol and fasting blood glucose, and lower integrative hematologic markers of immune reactivity. The M/HDL was maximal in patients with bent gallbladder body, which was accompanied by the elevated values of very low density lipoproteins cholesterol (0.80 ± 0.10 mmol/l), triglycerides (1.76 ± 0.21 mmol/l), both Castelli indices and lower high-density lipoprotein cholesterol. An inverse correlation of M/HDL with left ventricular ejection fraction was found in patients with intact gallbladder.
Conclusions. 1. M/HDL is a valuable marker of atherosclerosis and inflammation. 2. M/HDL was maximal in patients with bent gallbladder body, which was accompanied by dyslipidemia. 3. The inverse correlation of M/HDL with left ventricle ejection fraction in case of intact gallbladder and direct correlation with the aorta diameter in patients with cholecystitis confirm the association of the increase of this ratio with the unfavorable course of cardiovascular diseases. 4. In patients with UA and intact gallbladder or cholelithiasis M/HDL correlated with the nuclear index of intoxication.
Downloads
References
Chapman CM, Beilby JP, McQuillan BM, et al. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke. 2004;35:1619–1624. https://doi.org/10.1161/01.STR.0000130857.19423.ad
Moreno PR, Purushothaman KR, Fuster V, et al. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation. 2002; 105: 2504–2511. https://doi.org/10.1161/01.cir.0000017265.52501.37
Hafiane A, Genest J. High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk. BBA Clin. 2015;3:175–188. https://doi.org/10.1016/j.bbacli.2015.01.005
Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010; 37: 710–718. https://doi.org/10.1111/j.1440–1681.2009.05338.x
Yvan-Charvet L, Pagler T, Gautier EL, et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 2010; 328: 1689–1693. https://doi.org/10.1126/science.1189731
Murphy AJ, Westerterp M, Yvan-Charvet L, Tall AR. Anti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cells. Biochem Biophys Acta. 2012;1821:513–521. https://doi.org/10.1016/j.bbalip.2011.08.003
Nicholls SJ, Tuzcu EM, Sipahi I, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA. 2007; 297: 499–508. https://doi.org/10.1001/jama.297.5.499
Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005; 46: 1118–1122. https://doi.org/10.1161/01.HYP.0000185463.27209.b0
Villanueva DLE, Tiongson MD, Ramos JD, et al. Monocyte to High-Density Lipoprotein Ratio (MHR) as a predictor of mortality and Major Adverse Cardiovascular Events (MACE) among ST Elevation Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis. Lipids in health and disease. 2020; 19 (1): 55. https://doi.org/10.1186/s12944-020-01242-6
Sharma M, Somani P, Sunkara T. Imaging of gall bladder by endoscopic ultrasound. World J Gastrointest Endosc. 2018;10(1):10-15. https://doi.org/10.4253/wjge.v10.i1.10
Saskin H, Serhan Ozcan K, Yilmaz S. High preoperative monocyte count/high-density lipoprotein ratio is associated with postoperative atrial fibrillation and mortality in coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2016; pii: ivw376. https://doi.org/10.1093/icvts/ivw376
Açıkgöz K, Açıkgöz E, Şensoy B, Topal S, Aydoğdu S. Monocyte to high-density lipoprotein cholesterol ratio is predictive of in-hospital and five-year mortality in ST-segment elevation myocardial infarction. Cardiol J. 2016; 23 (5): 505–512. https://doi.org/10.5603/CJ.a2016.0026
Wu TT, Zheng YY, Chen Y, et al. Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention. Lipids Health Dis. 2019;18:180. https://doi.org/10.1186/s12944-019-1116-2
Serkan Cetin M, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. Heart, Lung and Circulation. 2016; 25 (11): 1077–1086. https://doi.org/10.1016/j.hlc.2016. 02.023
Korkmaz A, Demir M, Unal S, et al. Monocyte-to-high density lipoprotein ratio (MHR) can predict the significance of angiographically intermediate coronary lesions. International Journal of the Cardiovascular Academy. 2017; 3 (1–2): 16–20. https://doi.org/10.1016/j.ijcac.2017.05.008
Chen JW, Li C, Liu ZH, et al. The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes. Frontiers in Endocrinology. 2019; 10: 191. https://doi.org/10.3389/fendo.2019.00191
Canpolat U, Cetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost. 2016; 22: 476–482. https://doi.org/10.1177/1076029615594002
Yayla KG, Canpolat U, Yayla Ç, et al. A Novel Marker of Impaired Aortic Elasticity in Never Treated Hypertensive Patients: Monocyte/High-Density Lipoprotein Cholesterol Ratio. Acta Cardiol Sin. 2017;33(1):41–49. https://doi.org/10.6515%2FACS20160427A
Gazzin S, Vitek L, Watchko J, et al. Perspective on the Biology of Bilirubin in Health and Disease. Trends in molecular medicine. 2016;22:758–68. https://doi.org/10.1016/j. molmed.2016.07.004
Lai X, Fang Q, Yang L, et al. Direct, indirect and total bilirubin and risk of incident coronary heart disease in the Dongfeng-Tongji cohort. Ann Med. 2018; 50 (1): 16–25. https://doi.org/10.1080/07853890.2017.1377846
Shi Y, Hu L, Li M, et al. U-Shaped Association Between Serum Bilirubin Levels and Peripheral Arterial Disease in Chinese Males with Hypertension. Research Square; 2020. https://doi.org/10.21203/rs.3.rs-40589/v1
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
